Wang et al. [137] showed that the interaction between DVL1 and CtBP2 modulates the Wnt/β-catenin signaling pathway, influencing cell proliferation and drug sensitivity in NSCLC. The gene discussed is DVL1; the disease is non-small cell lung carcinoma.